Dare Bioscience Stock

Dare Bioscience Acquisitions (Net)

Acquisitions (Net) of Dare Bioscience (DARE) as of Sep 14, 2026.

Acquisitions (Net)

0.00USD

Last updated:

Acquisitions (Net) of Dare Bioscience is 2026 0.00 USD. Acquisitions (Net) of Dare Bioscience was 2025 0.00 USD. It decreases by % lower compared to the previous year.

The Dare Bioscience Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2014
40,000.00 USD
Jan 1, 2015
-210,000.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
9.92 M USD
Jan 1, 2018
-510,000.00 USD
Jan 1, 2019
6.14 M USD
Jan 1, 2020
0.00 USD
The Dare Bioscience Acquisitions (Net) history
YEARAcquisitions (Net)YoY
0.00USD-100.00%
6.14 MUSD-1,303.92%
-510,000.00USD-105.14%
9.92 MUSD—
0.00USD-100.00%
-210,000.00USD-625.00%
40,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

Dare Bioscience Stock analysis

What does Dare Bioscience do? Dare Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dare Bioscience stock

On Eulerpool you can find the complete historical development of Acquisitions (Net) Dare Bioscience since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Dare Bioscience historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Dare Bioscience

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Dare Bioscience